Format

Send to

Choose Destination
J Thorac Oncol. 2019 May;14(5):e85-e88. doi: 10.1016/j.jtho.2019.01.015. Epub 2019 Jan 31.

Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy.

Author information

1
Department of Respiratory Diseases and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
2
Medical Department, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, People's Republic of China.
3
Translational Medicine Research Institute, Geneseeq Technology Inc., Toronto, Ontario, Canada.
4
Translational Medicine Research Institute, Geneseeq Technology Inc., Toronto, Ontario, Canada; School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
5
Department of Respiratory Diseases and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China. Electronic address: yshu7661@sina.com.
PMID:
30711650
DOI:
10.1016/j.jtho.2019.01.015

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center